.
MergerLinks Header Logo

New Deal


Announced

Sia Partners to acquire Latham BioPharm Group.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Single Bidder

United States

Life science

Biotechnology

Private

biotechnology

Cross Border

Majority

Acquisition

Friendly

Pending

Synopsis

Edit

Sia Partners, a management consulting firm, agreed to acquire Latham BioPharm Group, a life sciences consulting company. Financial terms were not disclosed. "Since the creation of LBG, our ambition has been to help our clients save and improve lives through the funding and development of their Life Science offerings. The wave of scientific innovation we are experiencing is unprecedented, particularly at the intersection of the Life Sciences and Information Technologies. The merger with Sia Partners opens up new horizons for us, both geographically and in terms of access to new clients such as major players in the tech industry. It also strengthens our client offerings including in the areas of BioIT and digital health," Peter Latham, LBG Founder.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US